Affordable Access

Publisher Website

Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure.

Authors
Type
Published Article
Journal
Expert Opinion on Pharmacotherapy
1744-7666
Publisher
Informa UK (Taylor & Francis)
Publication Date
Volume
12
Issue
18
Pages
2771–2779
Identifiers
DOI: 10.1517/14656566.2011.626770
PMID: 21999703
Source
Medline

Abstract

The FDC of 20 mg enalapril-maleate and 10 mg lercanidipine-hydrochloride seems to be effective and well tolerated in clinical practice. It improved vascular surrogate end points, including pulse pressure, blood pressure variability and microalbuminuria.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments